A UK-based SME has developed a highly sensitive point-of-care diagnostic device for myocardial infarctions, heart attacks, based on a magnetic immunodetection platform assay technology. They are looking for expertise in microfluidics for optimisation of the microfluidic test strip component of the device. it is anticipated the partnership will be a research cooperation, a technical cooperation or a services agreement dependant in the individual situation.
Of the patients presenting with symptoms of myocardial infarction (MI, also known as a heart attack) each year only 10% of these are actual MI cases, the remainder are as a result of heart burn or other issues. It is essential that this 10% of cases are quickly identified to enable treatment to rapidly begin to ensure positive outcomes.
A UK-based SME is developing a point-of-care diagnostic device that detects troponin - a biomarker for myocardial infarction - from a small blood sample. The device is handheld and uses a disposable microfluidic test strip magnetic immunodetection platform technology intended to produce fully quantified, gold-standard results in minutes.
The company is looking for expertise in microfluidics, especially the use of such test strips within diagnostic devices. They need this expertise to optimise the microfluidic strip component of the device with the magnetic immunodetection component. This partnership can be with academic institutions or with industry and is envisaged to take the form of a research cooperation, a technical cooperation or a services agreement dependant on the type and circumstances of the partner.
- Type of partner sought: The UK-based SME is looking for expertise in microfluidics, especially in relation to the use of microfluidic test strips in diagnostic devices. The SME is looking for this expertise in order to optimise the microfluidic component of their device with the magnetic immunoassay platform technology that the device is based on.
- Specific area of activity of the partner: The UK-based SME is looking for partners with expertise in microfluidics particularly in relation to diagnostic devices. The SME is looking for this expertise in order to optimise the microfluidic component of their device with the magnetic immunoassay platform technology that the device is based on. This could be academic expertise or from companies that specialise in these strips or microfluidic technology. It is expected that the partnership will be in the form of a research cooperation agreement, a technical cooperation agreement or a services agreement. This will depend on the nature of the partner and their circumstances.
Under development/lab tested
Secret Know-how,Patent(s) applied for but not yet granted